Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Prevalence of Opioid, Gabapentinoid, and NSAID Use in Patients with CKD.

Literature DB >> 30409899

Prevalence of Opioid, Gabapentinoid, and NSAID Use in Patients with CKD.

Tessa K Novick¹, Aditya Surapaneni², Jung-Im Shin², Shoshana H Ballew^2,3, G Caleb Alexander³, Lesley A Inker⁴, Alex R Chang⁵, Morgan E Grams⁶.

Abstract

Entities: Chemical Disease Species

Keywords: Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Opioid; Prevalence; Renal Insufficiency, Chronic; chronic kidney disease; chronic pain; pain medications

Mesh：

Substances：

Year: 2018 PMID： 30409899 PMCID： PMC6302317 DOI： 10.2215/CJN.08530718

Source DB: PubMed Journal: Clin J Am Soc Nephrol ISSN： 1555-9041 Impact factor: 8.237

× No keyword cloud information.

5 in total

Review 1. The metabolism of opioid agents and the clinical impact of their active metabolites.

Authors: Howard S Smith
Journal: Clin J Pain Date: 2011 Nov-Dec Impact factor: 3.442

2. Pain, analgesics, and safety in patients with CKD.

Authors: Sara N Davison
Journal: Clin J Am Soc Nephrol Date: 2015-02-20 Impact factor: 8.237

3. New Data on Opioid Use and Prescribing in the United States.

Authors: Anne Schuchat; Debra Houry; Gery P Guy
Journal: JAMA Date: 2017-08-01 Impact factor: 56.272

4. Pharmacokinetics and metabolism of gabapentin in rat, dog and man.

Authors: K O Vollmer; A von Hodenberg; E U Kölle
Journal: Arzneimittelforschung Date: 1986-05

5. A new equation to estimate glomerular filtration rate.

Authors: Andrew S Levey; Lesley A Stevens; Christopher H Schmid; Yaping Lucy Zhang; Alejandro F Castro; Harold I Feldman; John W Kusek; Paul Eggers; Frederick Van Lente; Tom Greene; Josef Coresh
Journal: Ann Intern Med Date: 2009-05-05 Impact factor: 25.391

5 in total

1. Association of Opioids and Nonsteroidal Anti-inflammatory Drugs With Outcomes in CKD: Findings From the CRIC (Chronic Renal Insufficiency Cohort) Study.

Authors: Min Zhan; Rebecca M Doerfler; Dawei Xie; Jing Chen; Hsiang-Yu Chen; Clarissa J Diamantidis; Mahboob Rahman; Ana C Ricardo; James Sondheimer; Louise Strauss; Lee-Ann Wagner; Matthew R Weir; Jeffrey C Fink
Journal: Am J Kidney Dis Date: 2020-04-18 Impact factor: 8.860

5. Frailty modifies the association between opioid use and mortality in chronic kidney disease patients with diabetes: a population-based cohort study.

Authors: Szu-Ying Lee; Jui Wang; Chia-Ter Chao; Kuo-Liong Chien; Jenq-Wen Huang
Journal: Aging (Albany NY) Date: 2020-11-07 Impact factor: 5.682

5 in total

Prevalence of Opioid, Gabapentinoid, and NSAID Use in Patients with CKD.

Review 1. The metabolism of opioid agents and the clinical impact of their active metabolites.

2. Pain, analgesics, and safety in patients with CKD.

3. New Data on Opioid Use and Prescribing in the United States.

4. Pharmacokinetics and metabolism of gabapentin in rat, dog and man.

5. A new equation to estimate glomerular filtration rate.

1. Association of Opioids and Nonsteroidal Anti-inflammatory Drugs With Outcomes in CKD: Findings From the CRIC (Chronic Renal Insufficiency Cohort) Study.

2. Associations of Opioid Prescriptions with Death and Hospitalization across the Spectrum of Estimated GFR.

3. Can NSAIDs be used safely for analgesia in patients with CKD?: PRO.

Review 4. The Role of Opioids in Pain Management in Elderly Patients with Chronic Kidney Disease: A Review Article.

5. Frailty modifies the association between opioid use and mortality in chronic kidney disease patients with diabetes: a population-based cohort study.